A phase II study of erlotinib and sorafenib in chemotherapy-naive patients with locally advanced/metastatic non-small cell lung cancer (NSCLC)

J.S.W. Lind, A.C. Dingemans, H.J.M. Groen, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)S412-S413
JournalJournal of Thoracic Oncology
Volume4
Issue number9
Publication statusPublished - 2009

Cite this